Balance Sheet for CollPlant Biotechnologies Ltd. (CLGN)

$ 4.48 0.00 (0.00%) Volume: 2 3:00 PM EDT 17-Oct-2019
Statement: View:
Assets [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Cash and Equivalents 5,328 5,126 987 1,362 2,841
Restrictable Cash 155 - - - -
Marketable Securities - - - - -
Accounts Receivable 513 102 779 368 288
Loans Receivable - - - - -
Other Receivables 103 392 8 16 9
Receivables 742 627 950 469 355
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other 810 201 127 - -
Inventories, Adjustments & Allowances - - - - -
Inventories 810 201 127 - -
Prepaid Expenses 104 494 34 362 42
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 7,139 6,449 2,098 2,192 3,238
Land and Improvements - - - - -
Buildings and Improvement 1,509 934 750 267 251
Machinery, Furniture and Equipment 2,730 2,801 2,509 2,388 2,055
Construction in Progress - - - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total 4,239 3,735 3,259 2,655 2,305
Gross Fixed Assets 4,239 3,735 3,259 2,655 2,305
Accumulated Depreciation (2,839) (2,705) (2,217) (1,986) (1,790)
Net Fixed Assets 1,400 1,031 1,042 669 515
Intangibles 338 418 424 441 443
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 154 145 145 145 145
Total Non-Current Assets 1,910 1,620 1,654 1,273 1,117
Total Assets 9,049 8,069 3,752 3,466 4,355
Liabilities [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Accounts Payable 619 841 1,769 961 680
Short Term Debt 22 - - - -
Notes Payable - - - - -
Accrued Expenses 628 574 - - -
Accrued Liabilities 628 574 - - -
Deferred Revenues 965 - - - -
Current Deferred Income Taxes - - - - -
Other Current Liabilities - - - - -
Total Current Liabilities 2,235 1,415 1,769 961 680
Long Term Debt 22 3,636 - - -
Deferred Income Tax 975 - - - -
Other Non-Current Liabilities 2,033 404 641 - -
Minority Interest - - - - -
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 2,055 4,041 641 - -
Total Liabilities 4,290 5,456 2,411 961 680
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 4,760 2,613 1,341 2,505 3,675
Common Par 1,518 1,438 834 683 620
Additional Paid in Capital 52,273 51,349 41,560 36,044 33,621
Cumulative Translation Adjustments - - - - -
Retained Earnings (49,031) (50,173) (41,052) (34,222) (30,566)
Treasury Stock - - - - -
Other Equity Adjustments - - - - -
Total Capitalization 4,782 6,250 1,341 2,505 3,675
Total Equity 4,760 2,613 1,341 2,505 3,675
Total Liabilities & Shareholder's Equity 9,049 8,069 3,752 3,466 4,355
Cash Flow (3,780) (5,990) (7,193) (4,810) (3,344)
Working Capital 4,904 5,034 328 1,232 2,559
Free Cash Flow (2,031) (5,274) (5,165) (4,070) (3,414)
Invested Capital 4,782 6,250 1,341 2,505 3,675
Shares Outstanding - Common Class Only 3,815 3,336 2,161 1,776 1,609
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 3,815 3,336 2,161 1,776 1,609
Total Common Shares Outstanding 3,815 3,336 2,161 1,776 1,609
Treasury Shares - 18 - - -
Basic Weighted Shares Outstanding 4,385 2,664 2,012 1,693 1,609
Diluted Weighted Shares Outstanding 4,385 2,664 2,012 1,693 1,609